1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
AbbVie Stockholders Elect Class II Directors and Ratify Auditor Appointment
Reports First-Quarter 2026 Financial Results
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
Annual Report to Security Holders
AbbVie Completes $750 Million Senior Notes Offering
AbbVie Enters Underwriting Agreement for $750M Senior Notes Offering
Reports Full-Year and Fourth-Quarter 2025 Financial Results
Q1
FY 2024
Q3
Q2
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Additional Proxy Soliciting Materials
Statement of Changes in Beneficial Ownership
Free Writing Prospectus
Specialized Disclosure Report
Amended Notice of Proposed Sale of Securities